Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Tolerability of MZRW in Healthy Subjects
NCT02359396Phase 1Completed
- Sponsor
- Hong Kong Baptist University
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mazirenwan in functional constipation (FC) (3 arms), sponsored by Hong Kong Baptist University. Primary endpoint: Number of Participants with Adverse Events as a Measure of Safety and Tolerability at 12 hours. Started Nov 2014; status: completed.
02
Drugs
mazirenwan
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT02359396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359396.